RT Journal Article
SR Electronic
T1 Digital nuclear morphometry correlates to BAP-1 expression, gene expression class and metastasis-free survival in uveal melanoma
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19010215
DO 10.1101/19010215
A1 Christina Herrspiegel
A1 Thonnie Rose O. See
A1 Pia R. Mendoza
A1 Hans E. Grossniklaus
A1 Gustav Stålhammar
YR 2019
UL http://medrxiv.org/content/early/2019/10/25/19010215.abstract
AB Cytologic features such as the shape and size of tumor cells can predict metastatic death in uveal melanoma, but suffer from poor reproducibility. In this study, we investigate the interobserver concordance of digital morphometry, and correlate the results with established prognostic markers. The average number of cells analyzed in each of 27 tumors, was 1957 (SD 349). Mean time consumption was less than 2.5 minutes per tumor. Identical morphometric classification was obtained for ≥ 85 % of tumors in all twelve evaluated morphometric variables (κ 0.70–0.93). The mean nucleus area, nucleus perimeter, nucleus max caliper and nucleus to cell area ratio were significantly greater in tumors with low nuclear BRCA associated protein-1 expression (nBAP-1) and gene expression class 2. Patients had significantly shorter metastasis-free survival if their tumors had low nBAP-1 expression (Log-Rank p=0.002), gene expression class 2 (Log-Rank p=0.004) or tumor cell nuclei with long max calipers (Log-Rank p=0.004) as defined in a training cohort and then tested in a validation cohort. We conclude that digital morphometry can be fast and highly reproducible, that for the first time, morphometry parameters can be objectively quantitated in thousands of cells at a time, and that variables describing the shape and size of the nuclei correlate to nBAP-1 expression, gene expression class and prognosis in uveal melanoma.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by Cancerfonden, Karolinska Institutet (Karolinska Institutets stiftelsemedel för ögonforskning) and Stockholm County Council (Stockholms läns landsting).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll data analyzed during this study are included in this published article. The raw datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.